Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of ...

Through Colorado’s Path4EMS program, a mental health clinic reduces ketamine infusion costs from $400 to $150, making treatment more accessible for first responders ...

Esketamine, the ketamine-derived nasal spray sold under the brand name Spravato (esketamine), is indicated for patients with treatment-resistant depression. In October 2023, the FDA warned about ...

making the nasal spray the only authorized standalone therapy for treatment-resistant depression. According to Reilly, IV and intramuscular ketamine have not received FDA approval because they ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression. No More Pricking: US FDA Approves ...

Ketamine is often viewed more as a party drug than a medicine. One Columbia clinic is using the drug to help patients with ...

A Greenwood Village mental health clinic said they are the first to provide ketamine therapy that they say is affordable to ...

Ketamine therapy is used in the treatment ... LifeStance Health in Oklahoma also provides nasal spray Spravato (esketamine), another therapeutic option for treatment-resistant depression.

The Daily Gate mobile app brings you the latest local breaking news, updates, and more. Read the Daily Gate on your mobile device just as it appears in print.